Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 10 of 25
Pre-oxygenation With Real Time End-tidal Oxygen Measurements Versus Single Breath Measurements
NCT03840486
UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)
NCT04075656
Trikafta in Cystic Fibrosis Patients
NCT03506061
Clarithromycin Mechanisms in Hypersomnia Syndromes
NCT04026958
Lipid Challenge in Adults
NCT03948295
Compassion-Centered Spiritual Health for Faculty and Staff
NCT04060901
Feasibility of EnChroma Use in the Emergency Department Setting
NCT04021914
In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
NCT03932240
Carepartner Collaborative Integrated Therapy in Sub-Acute Stroke
NCT04040751
Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy
NCT03939819
Emory Teaching Kitchen Collaborative
NCT04005495
Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow
NCT02757885
Dexcom G6 Intervention Study
NCT03877068
Adolescent Idiopathic Scoliosis (AIS) Gold Standard for Blood Loss
NCT03990376
Neuroplastic Mechanisms Underlying Augmented Neuromuscular Training
NCT04069520
Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System
NCT03729570
Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone
NCT03704584
Structured Function-Based Elopement Treatment Program
NCT03899831
Dementia-Friendly Faith Villages to Support African American Families
NCT04983693
Ultrasound in Diagnosing Patients With Skin Lesions
NCT03914846
Pre-exposure Prophylaxis (PrEP) at Home
NCT03569813
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer
NCT03910387
Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer
NCT03819088
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
NCT03772314
Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)
NCT03818737
Determining the Benefits of Improving Communication in BPAP/CPAP Users
NCT03795753
Body Compartment Pharmacokinetics of Anti-retroviral Agents That May be Considered for Future On-demand Peri-exposure HIV Prophylaxis Regimens
NCT03976752
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
NCT03743025
Developing a Lifestyle Intervention for South Asians
NCT03861546
Dexcom G6 Observational Study
NCT03832907
Syngery-Evaluating the Impact of Decision Aid
NCT03832868
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
NCT03691493
Reducing Disparities in Living Donor Transplant Among African Americans
NCT03819686
Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
NCT03506048
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
NCT03800602
IDegLira HIGH Trial
NCT03737240
Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery
NCT03882450
Resistance Training to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors
NCT03539835
Contraceptive Hormones, Immunity, and Microbiome Evaluation
NCT03660046
Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes
NCT03562767
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
NCT03680144
Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
NCT03739619
Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials
NCT03543878
THRIVE Breast Cancer App Study
NCT03592771
Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
NCT03694548
Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants
NCT03232931
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
NCT03605719
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
NCT03686514
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response
NCT03701061
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
NCT03579771
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.